NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia.
Kimura S, Naito H, Segawa H, Kuroda J, Yuasa T, Sato K, Yokota A, Kamitsuji Y, Kawata E, Ashihara E, Nakaya Y, Naruoka H, Wakayama T, Nasu K, Asaki T, Niwa T, Hirabayashi K, Maekawa T.
Kimura S, et al. Among authors: ashihara e.
Blood. 2005 Dec 1;106(12):3948-54. doi: 10.1182/blood-2005-06-2209. Epub 2005 Aug 16.
Blood. 2005.
PMID: 16105974
Free article.